Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,925 | -92,273 | -46,284 | 53,815 | -38,463 |
| Depreciation Amortization | 3,018 | 3,775 | 1,201 | 1,097 | 1,188 |
| Accounts receivable | -12,216 | -5,043 | -11 | 44 | 284 |
| Other Working Capital | -19,099 | 5,675 | -3,212 | 188 | 5,853 |
| Other Operating Activity | 14,727 | 29,917 | 1,107 | -91,329 | -1,406 |
| Operating Cash Flow | $-24,495 | $-57,949 | $-47,199 | $-36,185 | $-32,544 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 211 | -9,761 | -48,206 | 8,980 | 26,117 |
| PPE Investments | -593 | -1,646 | -753 | -685 | -294 |
| Purchase Sale Intangibles | -2,277 | N/A | 0 | 0 | N/A |
| Other Investing Activity | -2,277 | -705 | 0 | 25,607 | 0 |
| Investing Cash Flow | $-2,659 | $-12,112 | $-48,959 | $33,902 | $25,823 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 90,000 | 0 | 30,000 | N/A |
| Debt Repayment | N/A | -24,344 | -6,775 | 0 | N/A |
| Common Stock Issued | 571 | 2,437 | 100,735 | 29 | 4 |
| Other Financing Activity | 29,999 | -5,354 | -6,044 | -2,942 | -948 |
| Financing Cash Flow | $30,570 | $62,739 | $87,916 | $27,087 | $-944 |
| Beginning Cash Position | 32,980 | 40,302 | 48,544 | 23,740 | 31,405 |
| End Cash Position | 36,396 | 32,980 | 40,302 | 48,544 | 23,740 |
| Net Cash Flow | $3,416 | $-7,322 | $-8,242 | $24,804 | $-7,665 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,495 | -57,949 | -47,199 | -36,185 | -32,544 |
| Capital Expenditure | -593 | -1,646 | -753 | -685 | -294 |
| Free Cash Flow | -25,088 | -59,595 | -47,952 | -36,870 | -32,838 |